Iterum Therapeutics plc (ITRM)
收市後：
| 前收市價 | 1.5600 |
| 開市 | 1.5900 |
| 買盤 | 1.6400 x 100 |
| 賣出價 | 1.7200 x 100 |
| 今日波幅 | 1.5200 - 1.7200 |
| 52 週波幅 | 0.6220 - 2.5000 |
| 成交量 | |
| 平均成交量 | 615,587 |
| 市值 | 27.433M |
| Beta 值 (5 年，每月) | 2.36 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -2.9600 |
| 業績公佈日 | 2024年5月10日 - 2024年5月14日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 6.50 |
Insider MonkeyIterum Therapeutics plc (NASDAQ:ITRM) Q4 2023 Earnings Call Transcript
Iterum Therapeutics plc (NASDAQ:ITRM) Q4 2023 Earnings Call Transcript March 28, 2024 Iterum Therapeutics plc beats earnings expectations. Reported EPS is $-0.94, expectations were $-1.02. ITRM isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello, everyone, and welcome to the […]
ZacksIterum (ITRM) Plans Early Submission of UTI Drug NDA, Stock Up
Iterum (ITRM) stock rises as the company gears up to submit a regulatory application to the FDA seeking approval for oral sulopenem to treat adult women with uUTIs ahead of schedule.
Insider MonkeyIterum Therapeutics plc (NASDAQ:ITRM) Q3 2023 Earnings Call Transcript
Iterum Therapeutics plc (NASDAQ:ITRM) Q3 2023 Earnings Call Transcript November 14, 2023 Operator: Hello, everyone, and welcome to the Iterum Therapeutics Third Quarter 2023 Financial Results and Business Update. My name is Harry, and I’ll be your operator today. [Operator Instructions] And I will now hand the call over to Louise Barrett, Senior Vice President, […]
